ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Activity

20 hedge funds and large institutions have $8.79M invested in Enlivex Therapeutics in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-3
Holders Change %
-13.04%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
6
Closed
7
Calls
$286K
Puts
$1.42M
Net Calls
-$1.13M
Net Calls Change
+$463K

Top Buyers

1
AIM
ARK Investment Management
Florida
+$342K
2
BCV
Banque Cantonale Vaudoise
Switzerland
+$89K
3
UBS Group
UBS Group
Switzerland
+$22.8K
4
Wells Fargo
Wells Fargo
California
+$13.4K
5
ASN
Advisory Services Network
Georgia
+$8K

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$843K
2
Marshall Wace
Marshall Wace
United Kingdom
-$376K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$236K
4
GG
Golden Green
South Carolina
-$212K
5
Goldman Sachs
Goldman Sachs
New York
-$144K
Name Holding Trade Value Shares
Change 		Shares
Change %
SWA
26
SOA Wealth Advisors
New York
– -$3K -327 Closed
NFG
27
Next Financial Group
Texas
– -$1K -125 Closed
1
2